Immatics (IMTX) Cash from Operations (2019 - 2025)
Immatics (IMTX) reported Cash from Operations of 68288612.79 for Q4 2025, down 9.28% on a YoY basis from 75277519.82 in Q4 2024, and down 30.68% sequentially from 52256762.58 in Q3 2025.
Immatics (IMTX) Cash from Operations (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Cash from Operations data on file, last reported at 68288612.79 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations fell 9.28% year-over-year to 68288612.79; the trailing twelve-month figure through Dec 2025 stood at 200734820.13 (down 17.58% YoY), and the FY2025 full-year result was 199554031.22, down 16.67% from the prior year.
- Cash from Operations fell to 68288612.79 in Q4 2025, from 52256762.58 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 120527847.57 in Q1 2022 to a low of 68288612.79 in Q4 2025.
- A 5-year average of 17831756.29 and a median of 32658036.14 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations surged 699.87% in 2022 and sank 397.17% in 2024, its largest moves.
- Tracing IMTX's Cash from Operations over 5 years: stood at 28900138.14 in 2021, then retreated by 11.02% to 32085759.39 in 2022, then soared by 365.17% to 85082100.18 in 2023, then slumped by 173.44% to 62487184.62 in 2024, then retreated by 9.28% to 68288612.79 in 2025.
- Business Quant data shows IMTX's Cash from Operations at 68288612.79 in Q4 2025, 52256762.58 in Q3 2025, and 44208685.61 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | -68.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -68.29 Mn |
| Dec 31, 2025 | -68.29 Mn |
| Sep 30, 2025 | -52.26 Mn |
| Sep 30, 2025 | -52.26 Mn |
| Jun 30, 2025 | -44.21 Mn |
| Jun 30, 2025 | -44.21 Mn |
| Mar 31, 2025 | -35.98 Mn |
| Mar 31, 2025 | -35.98 Mn |
| Dec 31, 2024 | -62.49 Mn |
| Dec 31, 2024 | -62.49 Mn |
| Sep 30, 2024 | -37.04 Mn |
| Sep 30, 2024 | -37.04 Mn |
| Jun 30, 2024 | -35.77 Mn |
| Jun 30, 2024 | -35.77 Mn |
| Mar 31, 2024 | -35.42 Mn |
| Mar 31, 2024 | -35.42 Mn |
| Dec 31, 2023 | 85.08 Mn |
| Dec 31, 2023 | 85.08 Mn |
| Sep 30, 2023 | -33.23 Mn |
| Sep 30, 2023 | -33.23 Mn |